Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,255 | -7,315 | 2,167 | 12,170 | 11,340 |
| Depreciation Amortization | 1,368 | 913 | 456 | 880 | 396 |
| Income taxes - deferred | -1,706 | -1,815 | 516 | -300 | N/A |
| Accounts receivable | -2,547 | 3,728 | 717 | -5,332 | -2,932 |
| Other Working Capital | -3,476 | 1,385 | 1,772 | -8,520 | -1,531 |
| Other Operating Activity | 14,579 | 5,829 | 118 | 9,872 | 4,574 |
| Operating Cash Flow | $-5,037 | $2,724 | $5,747 | $8,770 | $11,848 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -11 | -14 | N/A | -110 | -106 |
| Net Acquisitions | -822 | -822 | -822 | -4,030 | N/A |
| Other Investing Activity | 1,760 | 554 | 0 | -2,190 | -2,191 |
| Investing Cash Flow | $927 | $-282 | $-822 | $-6,330 | $-2,297 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1,122 | 1,118 |
| Other Financing Activity | -791 | -791 | 0 | -342 | -335 |
| Financing Cash Flow | $-791 | $-791 | $N/A | $780 | $783 |
| Exchange Rate Effect | 49 | 88 | 74 | 530 | 462 |
| Beginning Cash Position | 16,972 | 16,972 | 16,972 | 13,210 | 13,211 |
| End Cash Position | 12,120 | 18,710 | 21,970 | 16,970 | 24,007 |
| Net Cash Flow | $-4,852 | $1,738 | $4,999 | $3,760 | $10,795 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,037 | 2,724 | 5,747 | 8,770 | 11,848 |
| Capital Expenditure | -33 | -14 | N/A | -111 | -106 |
| Free Cash Flow | -5,070 | 2,710 | 5,747 | 8,659 | 11,742 |